CCaTS: Accelerating Discoveries Toward Better Health
Mayo Clinic's Center for Clinical and Translational Science (CCaTS) is funded by the National Institute of Health's (NIH) Clinical and Translational Science Awards program, grant number UL1TR000135. The CCaTS program is led by the NIH's National Center for Advancing Translational Sciences (NCATS).
Launched in 2006, the program has expanded to 62 academic medical institutions across the country. The Mayo Clinic CCaTS is part of the national consortium to improve the way biomedical research is conducted across the country. Consortium members share a common vision to reduce the time it takes for laboratory discoveries to become treatments for patients and engage communities in clinical research efforts. It is also fulfilling the critical need to train a new generation of clinical researchers.
Mayo Clinic's CCaTS seeks to speed the translation of research results into therapies, tools and patient care practices that improve community health. CCaTS makes connections, finds best practices, bridges gaps, engages the community and builds on more than a century of Mayo Clinic medical research and education expertise.
The content of this website is solely the responsibility of the Mayo Clinic CCaTS and does not necessarily represent the official views of the NIH.
Richard Sharp, Ph.D., named director of the Mayo Clinic Office of the Responsible Conduct of Research
Richard Sharp, Ph.D., is the new director of the Mayo Clinic Office of the Responsible Conduct of Research. Dr. Sharp is a senior associate consultant II in the Division of Health Care Policy & Research, with a joint appointment in the Division of General Internal Medicine.
Clinical Research Unit transitions to Clinical Research and Trials Unit
The Mayo Clinic Center for Clinical and Translational Science (CCaTS) is announcing the transition of the Clinical Research Unit to the Clinical Research and Trials Unit (CRTU), along with a new charge-out model for users.